New insights into PTEN regulation mechanisms and its potential function in targeted therapies - 09/10/12
Corresponding author. Tel.: +86 531 88382490; fax: +86 531 88382490.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a tumor suppressor gene of phosphatased activity. Its low or lacking expression closely relates with tumor progress and poor prognosis. The regulation and function ascribed to PTEN have become more diverse since its discovery as a putative phosphatase mutated in many human tumors. PTEN function is positively and negatively regulated at the transcriptional level, as well as post-translationally by phosphorylation, oxidation and acetylation. Deregulation of PTEN is implicated in other human diseases in addition to cancers, including diabetes and obesity, modulation of PTEN level has widespread therapeutic applications to those tumorigenesis and non-tumor diseases. This review will summarize the new points on the regulation of PTEN and briefly discuss the potential therapeutic role of PTEN in some diseases.
Le texte complet de cet article est disponible en PDF.Keywords : PTEN, Transcriptional regulation, Post-translational regulation, Therapy target
Plan
Vol 66 - N° 7
P. 485-490 - octobre 2012 Retour au numéro
- Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice
- Cristina Maria de Souza, Luciana Fonseca de Carvalho, Tamara da Silva Vieira, Ana Cândida Araújo e Silva, Miriam Teresa Paz Lopes, Mônica Alves Neves Diniz Ferreira, Silvia Passos Andrade, Geovanni Dantas Cassali
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?